| Patients with active disease |
| Every 3 to 4 months |
| ROS including fever, fatigue, weight loss, visual disturbance, dyspnea, cough, palpitations, abdominal pain, numbness, tingling, lightheadedness, syncope |
| PE including skin exam, palpation of lymph nodes, lung exam |
| Lab tests based on sites of disease activity and medications |
| Spirometry, diffusing capacity, ambulatory oximetry (or 6 minute walk) |
| Every 6 months |
| Ophthalmologic exam, if on hydroxychloroquine |
| Every 12 months |
| CBC and differential |
| Creatinine |
| Calcium |
| AST, ALT, Alkaline phosphatase |
| 25 hydroxy vitamin D |
| 1,25 dihydroxy vitamin D |
| EKG, sooner if palpitations, lightheadedness, syncope |
| Ophthalmologic exam (slit lamp, fundoscopic, tonometric), sooner if visual disturbance |
| Chest radiograph |
| As indicated by symptoms or other tests |
| HRCT |
| Echocardiogram |
| Holter monitoring |
| Urinalysis |
| TSH (association of thyroid autoimmunity and sarcoidosis) |
| Bone density when glucocorticoid therapy initiated and then every 3 years |
| MRI with gadolinium if neurologic symptoms (unless diabetic) |
| Patients with inactive disease for 2 or more (?) years |
| Every 12 to 18 months |
| ROS including fever, fatigue, weight loss, visual disturbance, dyspnea, cough, palpitations, abdominal pain, numbness, tingling, lightheadedness, syncope |
| PE including skin exam, palpation of lymph nodes, lung exam |
| Spirometry, diffusing capacity, ambulatory oximetry (or 6 minute walk) |
| CBC and differential |
| Creatinine |
| Calcium |
| Liver enzymes |
| 1,25 dihydroxy vitamin D |
| EKG, sooner if palpitations, lightheadedness, syncope |
| Ophthalmologic exam, sooner if visual disturbance |
